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Abstract
Probe-based PCR is widely used for SNP (single nucleotide polymorphism) genotyping and pathogen nucleic acid detection
due to its simplicity, sensitivity and cost-effectiveness. However, the multiplex capability of hydrolysis probe-based PCR is
normally limited to one target (pathogen or allele) per fluorescence channel. Current fluorescence PCR machines typically
have 4–6 channels. We present a strategy permitting the multiplex detection of multiple targets in a single detection
channel. The technique is named Multiplex Probe Amplification (MPA). Polymorphisms of the CYP2C9 gene (cytochrome
P450, family 2, subfamily C, polypeptide 9, CYP2C9*2) and human papillomavirus sequences HPV16, 18, 31, 52 and 59 were
chosen as model targets for testing MPA. The allele status of the CYP2C9*2 determined by MPA was entirely concordant
with the reference TaqManH SNP Genotyping Assays. The four HPV strain sequences could be independently detected in a
single fluorescence detection channel. The results validate the multiplex capacity, the simplicity and accuracy of MPA for
SNP genotyping and multiplex detection using different probes labeled with the same fluorophore. The technique offers a
new way to multiplex in a single detection channel of a closed-tube PCR.
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Introduction
Recently, real-time PCR, which is carried out in a closed-tube
format, has become a very important tool for detection and
quantification of specific sequences in a sample [1–4]. Multiplex
PCR, which uses multiple pairs of primers to amplify multiple
target sequences simultaneously in a single PCR reaction, is likely
to be a more efficient approach than standard single primer-pair
PCR when multiple targets need to be detected [5–8].
Multiplex real-time PCR offers numerous advantages, including
time savings, elimination of contamination risk, reduced reagent
costs, increased throughput, conservation of precious sample
material and reliable results [9–12]. However, current probe-
based methods allow detection of only one target sequence per
fluorescence channel. The multiplex fluorescent PCR is therefore
limited by the availability of fluorescence dyes and channels; up to
five or six targets, depending on particular PCR machines, can be
detected simultaneously in the current platforms [5,13].
We have developed a novel multiplex detection method
(Multiplex Probe Amplification, MPA), which allows the detection
of up to four targets in a single detection channel, using current
standard instrumentation. As model targets against which to test
this approach, we selected CYP2C9*2 SNP genotyping, and
detecting and typing high-risk HPV sequences, each in a single
closed-tube reaction. Variations in CYP2C9 gene may lead to
differential responses and metabolism of numerous drugs, such as
warfarin. Multiple-tube PCR, sequencing and microarray hybrid-
isation techniques have been utilised for genotyping these SNPs
[14,15]. Human papillomavirus (HPV) is one of the most common
causes of sexually transmitted disease (STD) worldwide; high-risk
types of HPV can cause cervical cancer. Accurate molecular
diagnosis is needed to inform patient management and follow-up
after treatment [16]. In this study, two alleles of one SNP or four
strains of a pathogen sequence were successfully genotyped in a
single detection channel. This opens up the prospect of multiplex
detection of far more targets in a single closed-tube reaction than
the 4–6 currently possible with conventional PCR technology.
Results
Principles and Melting Profile of Probes
The principles of MPA are as follows: Firstly, probes labeled
with the same fluorescence dyes can be distinguished if the probes
themselves, independent of hybridising to target sequence, have
different melting temperatures. Differential melting temperatures
for free probes can be arbitrarily arranged by providing
complementary oligonucleotide with sequences of varying length,
base composition and/or complementarity to the target-hybridis-
ing oligonucleotide. Secondly, if a target is present, its corre-
sponding probe is consumed during PCR amplification. Compar-
ing melting profiles of the probes after the reaction reveals which
probes have been consumed; this in turn indicates which targets
are present in a sample.
For each target we designed a probe consisting of two
oligonucleotides: a dual-labeled target-hybridising oligonucleotide
(THO) and a partially complementary oligonucleotide (PCO).
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30340THO is equivalent to the hydrolysis probe in the traditional
TaqMan PCR method. THO and PCO are capable of hybridising
to each other, forming a partially double-stranded probe (Figure 1).
By design, each probe has unique melting properties, which are
characterised by its melting temperature (Tm). THO, which is
complementary to a target sequence, is labeled with a fluorophore
at the 59 end and a quencher at the 39 end. PCO has its 39 end
blocked by modifying the 39 end, for example, by attaching a label
or a phosphate group, so that it cannot be extended. If the 39 end
of PCO comprises a moiety which is not a quencher (Figure 1A
and 2A), fluorescence emission is at the highest amount when
THO and PCO are hybridised. The fluorescence emission is
Figure 1. Nucleic acid probe design and its melting profile. (A) Probe consists of a target-hybridising oligonucleotide (THO) labeled with a
Fluorophore at the 59 end and a Quencher at the 39end, and a partially complementary oligonucleotide (PCO) without a label. The hybrid of THO:PCO
is named plus probe. The melting curve shows decreased fluorescence emission when temperature rises (left panel); the negative derivative plot of
the emission reading versus temperature reveals a positive value of the melting peak (right panel). (B) Minus probe consists of a THO labeled with a
Fluorophore at the 59 end and a Quencher at the 39end, and a PCO labeled with a Quencher at the 39 end. The melting curve shows increased
fluorescence emission when temperature rises (left panel); the negative derivative plot of the emission reading versus temperature reveals a negative
value of the melting peak (right panel).
doi:10.1371/journal.pone.0030340.g001
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duplex (Figure 1A, the left panel). The reason for this phenomenon
is that a linear single-stranded dual-labeled oligonucleotide in
solution behaves like a random coil: its two ends occasionally come
close to one another, resulting in a measurable change in energy
transfer. However, when the dual-labeled oligonucleotide binds to
its template, the labeled oligonucleotide/template hybrid forces
the two ends of the probe apart, disrupting the interaction between
the two terminal labels, and thus causing a fluorescence emission
change. The derivative melting plot shows a positive value
(Figure 1A, the right panel), thus this type of probe is termed
‘plus probe’ (+THO:PCO).
If PCO is labeled with a quencher at the 39 end (Figure 1B),
fluorescence emission is decreased by hybridisation of THO and
PCO and increases when the temperature increases to denature
the duplex (Figure 1B, left panel). This is because formation of the
THO:PCO hybrid brings the quencher and the fluorophore
into close proximity, efficiently quenching the fluorescent signal.
The derivative melting plot shows a negative value (Figure 1B,
right panel), thus this type of probe is termed ‘minus probe’
(-THO:PCO).
In a multiplex PCR reaction of this system, there are at least two
probes for two different targets, which are labeled with the same
fluorophore. To distinguish them, each probe is designed to have a
unique Tm which can be recognised in a melting curve analysis.
For example, we designed two probes: one for HPV16 sequence
and one for HPV18 sequence, which are both plus probes
(Figure 2). HPV16 probe has a Tm of 46uC and HPV18 probe has
aT m of 37uC. These clearly show two peaks in the melting curve
(Figure 2b).
The target-hybridising oligonucleotide (THO) capable of
hybridising to the target sequence can be consumed during
amplification. In the absence of a target, THO is not consumed,
thus remains at the same concentration throughout the reaction.
The melting profile of the unconsumed probe does not change. In
the presence of a target, the THO preferentially hybridises to the
target sequences rather than to the PCO, because Tm of
THO:target is higher than the Tm of THO:PCO. As a result,
THO is consumed and its concentration decreases. The melting
peak of the consumed probe is reduced or disappears in the
melting curve analysis.
The key feature of consumption of THO could be achieved by
any of several methods. For example, THO might be incorporated
into a PCR product, where THO acts as a primer. In this study,
we designed the THO to work as a hydrolysis probe, which is
hydrolysed during the amplification [17]. The degradation of
THO, like ordinary probe-based real-time PCR, results in the
increase of fluorescence signal, which can be monitored during
PCR. In the mean time, during the melting curve analysis, the
degradation of THO results in the decrease or disappearance of its
signature melting peak, indicating that the corresponding probe is
being consumed, which in turn shows which target is amplified.
Plus Probes Detecting HPV16 and HPV18
To test this system, we designed probes and primers for
detecting the two most virulent and high risk HPV strains, HPV16
and HPV18, in a single fluorescent detection channel in a real-
time PCR machine. Two plus probes were designed, targeting the
E6/E7 region of the HPV genome sequence (Figure 2A). Real-
time PCR was performed to test the design. Probe hybrids
THO:PCO were pre-tested in a melting curve analysis to
determine the fluorescence levels, so that when they were mixed
together, they had similar heights of melting peaks (Figure 2B).
Five 10-fold serial dilutions (10
6 to 10
2 copies) of template plasmids
containing the target HPV sequences, and a no DNA negative
control, were PCR amplified, and fluorescence emission was
collected in the FAM channel. Typical real-time PCR amplifica-
tion plots for each series of template dilutions are shown in Figure 2
(panel C – HPV16, panel E – HPV18, panel G – HPV16+
HPV18). Melting profiles were obtained after amplification.
Compared with the negative control, when the target HPV16 is
present, the melting peak at 46uC in the melting curve has
disappeared (Figure 2D). When the target HPV18 is present, the
melting peak at 37uC has disappeared (Figure 2F). When both
targets HPV16 and HPV18 are present, the two melting peaks
have both disappeared (Figure 2H). The results clearly demon-
strate that HPV16 or HPV18 or both HPV16+HPV18 can be
detected individually and distinguished, even in the same detection
channel.
Plus Probes Genotyping SNP CYP2C9*2
To test if this method can be used for SNP genotyping, we
designed probes and primers for genotyping SNP CYP2C9*2 in a
single fluorescent detection channel in a real-time PCR machine.
Two plus probes were designed, one corresponds to the A allele
(c.430T) and one corresponds to the G allele (c.430C). ‘‘A’’ allele
probe has a Tm of 44uC; ‘‘G’’ allele probe has a Tm of 39uC. If a
particular SNP is present in a sample, its corresponding probe is
hydrolysed by the 59 nuclease activity of Taq polymerase during
amplification, resulting in an increase in fluorescence emission. We
genotyped 25 samples using this design. Figure 3 shows
amplification plots (Figure 3A) and melting curves (Figure 3B,
3C and 3D). The melting curve of a homozygous sample of ‘‘G’’
allele along with no amplification controls is shown in Figure 3B. A
heterozygous sample along with no amplification controls is shown
in Figure 3C. A homozygous of ‘‘A’’ allele along with the no
amplification controls is shown in Figure 3D. This result is 100%
in concordance with TaqManH SNP Genotyping Assays from
Applied Biosystems.
Minus Probes Detecting Four HPV Sequences
To test the approach further, with minus probes, different target
sequences and more independent targets per channel, we designed
four minus probes labeled with FAM dye for HPV16, HPV31,
HPV52 and HPV59 sequences. The probes’ THOs are comple-
mentary to the conserved L1 region of the HPV genome
sequences. HPV59 probe has a Tm of 35uC; HPV31 probe has
aT m of 43uC; HPV16 probe has a Tm of 51uC; and HPV52 probe
has a Tm of 57uC. After amplification, melting profiles were
performed. Compared with the negative control, each individual
HPV target sequences can be correctly distinguished in the FAM
detection channel (Figure 4A–D).
Sensitivity of the assays on genomic DNA
The limit of detection of the HPV assays using plus and minus
probes was evaluated in a real-time PCR format. HeLa cell line
genomic DNA containing HPV16 and SiHa cell line genomic
DNA containing HPV18 were serially diluted in 10-fold
increments. Real-time PCR assays were performed on the dilution
series and negative controls; all were performed in duplicate. The
HPV negative K562 cell line gDNA control and water control
were all negative. The HeLa cell genome used contains 10 to 50
copies of HPV18 DNA, whereas the SiHa cell genome contains a
single integrated copy of HPV16 [18]. A sensitivity of 0.03ng of
gDNA was determined for both plus and minus probe assays. As
0.03ng of human genomic DNA is about 10 genome equivalents,
this indicates that the assays can detect at least 10 copies of HPV16
Multiplex Detection and Genotyping
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human genomic DNA.
Discussion
Compared with traditional hydrolysis probe-based PCR, this
MPA method comprises an extra oligonucleotide, which is capable
of hybridising to the labeled oligonucleotide. Since the extra
oligonucleotide hybridises to the labeled oligonucleotide at a
temperature lower than the annealing temperature, it does not
affect the PCR process. In other words, in terms of PCR
amplification there is no difference between this multiplex method
and the traditional hydrolysis probe PCR. Therefore, this new
method inherits all the benefits of the traditional hydrolysis probe-
based PCR, but with an extra benefit of being able to multiplex
using probes labeled with the same fluorophore and detection in a
single fluorescent channel.
To assess the scope and flexibility of MPA, we have also
performed experiments using additional fluorophores rather than
FAM, using plus and minus probes together, using minus probes
and a single-stranded probe, and even detecting all 14 high-risk
HPV strain sequences in a single-closed tube reaction. In one
experiment, four minus probes labeled with HEX dye were
designed, detecting HPV18, HPV39, HPV58 and HPV68
sequences (Figure S1A–D). In another experiment, a combination
of plus and minus probes was tested for detecting HPV33, HPV45
and HPV35 sequences (Figure S1E–G). A combination of minus
probe and single-stranded probe was also tested. Two minus
probes labeled with Cy5 dye for HPV56 and HPV66 sequences,
and one single stranded probe labeled with the same Cy5 dye for
HPV51 sequence were included in a PCR reaction (Figure S1I–J).
These experiments demonstrated that an individual HPV
sequence can be distinguished by using a combination of multiple
minus probes, plus probes and single-stranded probes.
When analysing the melting profiles, we have noticed that peaks
adjacent to the ‘true’ peak may also show a modest reduction in
peak height in minus probe assays for some HPV targets
(Figure 4C, S1A–B). This ‘‘shrunk neighbouring peaks phenom-
enon’’ could potentially lead to the erroneous conclusion that two
or more targets were present in the original template. In follow-up
experiments, using different PCR conditions and master mix, we
found this phenomenon to be assay-specific but highly reproduc-
ible. Though the origin of this effect remains unclear, it does not
affect the diagnostic specificity and accuracy of the assay – the
signature melting profile for single HPV target is clearly different
from the melting profiles for double or triple HPV targets. One
always can judge whether it is single, double or triple HPV
infection by comparing with reference melting profiles generated
from single and double target standards.
Recently, a novel method named Multicolor Combinatorial
Probe Coding (MCPC) was described for increasing the target
numbers of real-time PCR detection in one reaction [19]. This
strategy uses differently coloured fluorophores in various combi-
nations to label individual probes. It successfully detected up to 15
targets in a single reaction. However, one of the major limitations
of MCPC is that it is not suitable for simultaneous detection of
multiple targets in one reaction, as the colour overlaps between
singly labelled, doubly labelled, and multiply labelled probes
complicate the MCPC profiles. Fortunately MPA, with its different
and much simpler labelling strategy, does not suffer from this
limitation, indeed in our HPV assay we routinely detected multiple
targets in one reaction (Figure 2 and data not shown).
Our results demonstrate that it is possible to overcome the
current one-channel-one-target limitation. By this method a
greater number of target sequences can be analysed in a single
closed tube by designing sets of probes that hybridise to different
target sequences and have different melting temperatures. If a
target sequence is present, its corresponding probe is consumed.
The target can then be determined based on the comparison of the
melting profiles of the probes before and after the reactions.
Groups of probes in a set can be attached with the same label,
allowing for independent monitoring of multiple targets at a single
emission wavelength. Our method provides a significant improve-
ment over the current closed-tube multiplex PCR technology,
allowing for a 2–4 fold increase in the number of targets being
analysed in the current instruments.
Materials and Methods
Cell line genomic DNA and plasmid DNA
The HPV18 positive cervical HeLa cell DNA was purchased
from New England Biolabs; the HPV16 positive cervical SiHa cell
line was purchased from Abgent; the HPV negative K562 cell line
DNA was purchased from Promega. Genomic DNA was extracted
using GeneJET
TM Genomic DNA Purification Kit from Fermen-
tas according to manufacturer’s instruction. Plasmid DNAs
containing HPV sequences were synthesised by GeneArt. Serial
10-fold dilutions were undertaken to produce a titration series
representing from 30ng to 0.03ng/ml for genomic DNA, and 10
6
to 10
2 copies/ml for plasmid DNA.
Probe Design and Oligonucleotide Synthesis
Two plus probes were designed, targeting the E6/E7 region of
the HPV genome sequence. The target-hybridising oligonucleo-
tides (THOs) were synthesised with a FAM label at the 59 end and
a BHQ1 at the 39 end. The nucleotide sequence for HPV16 THO
is: 59 TTCAGGACCCACAGGAGCGACCC 39. The nucleotide
sequence for HPV18 THO is: 59 AGCCCCAAAATGAA-
ATTCCGGTTGACC 39. Partially complementary oligonucleo-
tides (PCOs) were synthesised with the same length as the THOs
and were attached with a phosphate group at the 39 end. The
nucleotide sequence for HPV16 PCO is: 59 GGGT-
TGCTTCTGTGAGTCTTGAA 39. The nucleotide sequence
for HPV18 PCO is: 59 GGTTAACTGGAGTTTTATTAT-
GAGGCT 39. A THO and PCO were combined at a ratio of
1:2 to form a partially double-stranded nucleic acid probe.
Forward and reverse primers were designed to be upstream and
downstream of the probe-binding region. The sequences for
HPV16 forward and reverse primers are 59 AGACATTTTATG-
CACCAAAAGAGAACT 39 and 59 TCTGTGCATAACTG-
Figure 2. Design of HPV16 and HPV18 probes and the use of the probes for amplification and melting curve analysis. (A) Hybrids of
THO:PCO are formed through hybridisation of THO and PCO. (B) Melting profile of the mix of HPV16 and HPV18 probes is plotted as the negative
derivative of the emission reading versus temperature. (C) is the graphic presentation of the amplification plot of PCR on five 10-fold serial dilutions
of HPV16 templates. (D) is the same reaction as (C) showing the melting curve. (E) is the graphic presentation of the amplification plot of PCR on five
10-fold serial dilutions of HPV18 templates. (F) is the same reaction as (E) showing the melting curve. (G) is the graphic presentation of the
amplification plot of PCR on five 10-fold serial dilutions of the mix of HPV16 and HPV18 templates. (H) is the same reaction as (G) showing the melting
curve.
doi:10.1371/journal.pone.0030340.g002
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forward and reverse primers are 59 GTATGCATGGACC-
TAAGGCAACA 39 and 59 TCGCTTAATTGCTCGTGACA-
TAGA 39, respectively. Oligonucleotides were synthesized by
Eurogentec.
Two plus probes were designed, targeting the SNP
CYP2C9*2. The target-hybridising oligonucleotides (THOs)
were synthesised with FAM at the 59 end and BHQ1 at the 39
end. The nucleotide sequence for the ‘‘G’’ allele probe is: 59
CTTGAACACGGTCCTCAATGC 39. The nucleotide se-
quence for the ‘‘A’’ allele probe is: 59 TCTTGAACA-
CAGTCCTCAATGCT 39. The partially complementary oligo-
nucleotide (PCO) was the same for both allele probes and was
attached with a phosphate group at the 39 end. The nucleotide
sequence of the PCO is: 59 GCATTAAGGACTGTGTC-
CAAGA 39. Forward and reverse primers were designed to be
upstream and downstream of the probe-binding region. The
sequences for forward and reverse primers are 59 TAAG
GTCAGTGATA TGGAGTAGG 39 and 59 GAATTGTTTT-
CAGCAATGGAAAGAA 39,r e s p e c t i v e l y .
Figure 3. Plus probes genotyping SNP CYP2C9*2. (A) is the graphic presentation of the amplification plot of PCR for genotyping SNP CYP2C9*2
on three genomic DNA samples and three negative controls. (B) is melting curves showing one sample is homozygous for G allele. (C) is melting
curves showing one sample is heterozygous. (D) is melting curves showing one sample is homozygous for A allele.
doi:10.1371/journal.pone.0030340.g003
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conserved L1 region that have the potential to detect all mucosal
HPV types were used in PCR detection with minus probes. PCR
amplification by BSGP5+/BSGP6+ has been described [20]. Four
minus probes labeled with FAM dye were designed, targeting the
conserved L1 region of the HPV genome sequences of HPV16,
HPV31, HPV52 and HPV59. The target-hybridising oligonucle-
otides (THOs) were synthesized with FAM at the 59 end and
BHQ1 at the 39 end. The nucleotide sequence for HPV16 probe
is: 59 CTGCCATATCTACTTCAGAAACTACATATAA 39.
The nucleotide sequence for HPV31 probe is: 59 CTGCAATTG-
CAAACAGTGATACTACATTTAA 39. The nucleotide se-
quence for HPV52 probe is: 59 CTGAGGTTAAAAAGGAAAG-
CACATATAAAAATG 39. The nucleotide sequence for HPV59
probe is: 59 CTTCTACTACTTCTTCTATTCCTAATGTA-
TAC 39. The partially complementary oligonucleotide (PCO) was
the same for HPV16 and HPV31 probes and was attached with a
Dabcyl group at the 39 end, having a sequence 59 TTATATG-
TAGTATCTGAGTTAGCTATGGCAG 39. The PCO for the
HPV52 probe was attached with a BHQ-1 group at the 39 end,
having a sequence 59 CATTTTTATATGTGCTGTCCTTAG-
TAACTTCAG 39. The PCO for the HPV59 probe was attached
with a BHQ-1 group at the 39 end, having a sequence 59
GTATATATTTGGTACAGGAGACTCTGTAGAAG 39.
Real-time PCR and Melting Profile Analysis
PCR reactions in a final volume of 25 ml consist of two equal
amounts of mix: 12.5 mlo f2 6FastStart Universal Probe master
(Rox) (Roche Diagnostics Gmbh, Mannheim Germany) and
12.5 ml primer/probe mix. Primer/probe mix was created as
follows: the primers and probes were mixed to a final
concentration of 0.4 mM of probes and 0.6 mM of primers, and
1 ml of various amount of target templates were added.
Amplification reactions and melting profiles were performed in a
Stratagene real-time PCR MX3005P system. The thermal profile
was: 95uC for 9 min 30 sec; 40 cycles of 95uC for 20 sec and 60uC
for 60 sec. Fluorescence measurements were recorded during the
read steps at 60uC. Post-amplification melting profile had the
following conditions: after the last cycle of PCR, heat at 95uC for
10 sec, cool to 30uC and hold for 30 sec, then slowly increase the
temperature to 80uC. The fluorescence emission data is contin-
ually collected during the rising temperatures. The negative
Figure 4. Melting curve analysis of the amplification reactions of various HPV targets. When a HPV target is present in a reaction, its
corresponding probe is consumed and, in comparison with the negative control, the appropriate melting peak in the melting profile is decreased or
has disappeared. The negative control melting curve is marked in red; the target melting curve is marked in blue. (A) HPV16 is present. (B) HPV31 is
present. (C) HPV52 is present. (D) HPV59 is present.
doi:10.1371/journal.pone.0030340.g004
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plotted against the temperature to form melting curves, and the
peak of the curve corresponds to the Tm of the probe.
Supporting Information
Figure S1 Melting curve analysis of the amplification
reactions of various HPV targets.
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